Nanobiotix Raises $71 Million in Royalty Monetization Deal with HealthCare Royalty to Boost Oncology Pipeline

Nanobiotix has entered a $71 million royalty monetization deal with HealthCare Royalty, unlocking the value of its intellectual property while retaining ownership. This rare and strategic move provides financial flexibility and supports future growth. The partnership highlights how patent monetization can drive collaboration, innovation, and long-term success in today’s competitive business landscape.

https://patentmonetize.com/nan....obiotix-royalty-mone